Press releaseGlobe Newswire
Stablecoin Development
NBY · NYSE
$0.83−$0.0084 (−1.00%)TodayMarket closed ·
Prev close $0.8384
Latest news
- Press releaseGlobe Newswire
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Gains 2%; D.R. Horton Earnings Top Views
- NewsAvi Kapoor
Dow Falls Over 500 Points; 3M Posts Upbeat Earnings
- NewsAvi Kapoor
J.B. Hunt Posts Mixed Q4 Results, Joins QXO And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- NewsAvi Kapoor
H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why RF Industries Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
US Stocks Lower; Dow Tumbles Over 250 Points
- NewsAvi Kapoor
Jefferson Capital, Mobix Labs And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Cybin, Xpeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Carnival Posts Strong Q4 Earnings, Joins Amicus Therapeutics, Biomarin Pharmaceutical And Other Big Stocks Moving Higher On Friday
- NewsAvi Kapoor
Kyverna Therapeutics, Immunome, Almonty Industries And Other Big Stocks Moving Higher On Monday
- NewsAvi Kapoor
Diamond Hill Investment Group, Rhythm Pharmaceuticals, Vail Resorts And Other Big Stocks Moving Higher On Thursday
- NewsAvi Kapoor
Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- NewsAvi Kapoor
Dow Falls Over 100 Points; Paychex Shares Fall After Q1 Results
- Press releaseGlobe Newswire
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- NewsAvi Kapoor
Crude Oil Gains Over 1%; UP Fintech Shares Plunge
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Dow Surges Over 100 Points; JM Smucker Earnings Miss Views
- News
Market-Moving News for August 27th
- NewsAvi Kapoor
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Nasdaq Down 1%; Lowe's Posts Upbeat Earnings
- NewsAvi Kapoor
Dow Surges 100 Points; Target Shares Fall After Q2 Results
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
- Press releaseBusiness Wire
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
- Press releaseBusiness Wire
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
- Press releaseBusiness Wire
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
- Press releaseBusiness Wire
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
- Press releaseBusiness Wire
NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
- Press releaseBusiness Wire
Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand
- Press releaseBusiness Wire
NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results
- Press releaseBusiness Wire
NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseBusiness Wire
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.